Okyo Pharma LTD 6-K Filing
Ticker: OKYO · Form: 6-K · Filed: Nov 18, 2025 · CIK: 1849296
Sentiment: neutral
Filing Stats: 440 words · 2 min read · ~1 pages · Grade level 14.1 · Accepted 2025-11-18 08:30:13
Filing Documents
- form6-k.htm (6-K) — 24KB
- ex99-1.htm (EX-99.1) — 14KB
- ex99-1_001.jpg (GRAPHIC) — 46KB
- 0001493152-25-023995.txt ( ) — 102KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. OKYO Pharma LTD Date: November 18, 2025 By: /s/ Keeren Shah Name: Keeren Shah Title: Chief Financial Officer 3 EXHIBIT INDEX Exhibit No. Description 99.1 News Announcement, dated November 18, 2025 4